The incision choice for breast augmentation involves real trade-offs across multiple outcome categories. Inframammary (under-breast fold) is most popular globally with best access for surgeon, lowest complication rates, and best sensation outcomes — but produces a scar in the fold. Periareolar (around the nipple) hides the scar in pigmented tissue but has higher rates of sensation changes, breastfeeding issues, and capsular contracture. Transaxillary (armpit) avoids breast scar entirely but has technical limitations. This guide details the trade-offs for each approach.
The three main incision approaches access the implant pocket through different routes.
Inframammary incision. 4-5 cm incision in the natural fold under the breast. Surgeon accesses pocket directly through subcutaneous tissue. Direct visualization of pocket creation. Standard approach for both round and anatomical implants, all sizes, all placement planes.
Periareolar incision. 4-5 cm semicircular incision around lower edge of areola. Surgeon accesses pocket through breast parenchyma (gland tissue) — passing through milk ducts and breast tissue to reach pocket. Limited dissection access, particularly for larger implants.
Transaxillary incision. 3-4 cm incision in armpit. Surgeon creates implant pocket through subcutaneous tissue from axilla, requiring extended dissection. Implant placed through axillary tunnel. Often performed with endoscopic assistance for visualization.
Less common: periumbilical (TUBA). Single incision in navel, implants placed through abdominal-thoracic dissection. Limited to specific saline implants only. Rare in modern practice.
The technical access difference. Inframammary provides direct visual control of pocket creation, hemostasis, implant placement. Periareolar requires more limited access — surgeon working through smaller window. Transaxillary requires longest dissection path, technical complexity. Direct access translates to better pocket control and lower complication rates.
The most patient-relevant question for many: how visible will my scar be?
Inframammary scar. Located in the natural fold under the breast where it typically remains hidden by breast itself. Visible only when breast is lifted (during examination, certain bra styles). Typically heals well — natural fold has good blood supply and minimal tension. Most patients consider these scars unobtrusive long-term.
Periareolar scar. Located along the lower edge of the areola in the pigmented border zone. The transition between pigmented areola and unpigmented breast skin makes the scar relatively inconspicuous if heals well. However: visible on close inspection, can become noticeable with poor scar healing, may produce contour irregularity at areolar edge.
Transaxillary scar. Located in armpit fold. Hidden by arm in normal position. Visible when arms raised (sleeveless tops, swimwear, exercise). Smaller scar than other approaches. Generally heals well in axillary skin.
Patient priorities. Patient who wants no breast scar visible to partner: transaxillary or possibly periareolar. Patient who wants scar invisible in clothing: any of the three. Patient prioritizing minimal complication risk over scar position: inframammary regardless.
Real-world scar appearance. All three approaches produce minimal scarring in patients with good healing. Patients with hypertrophic scarring tendencies or keloid risk may have problems with any incision. Skin tone affects scar visibility — pigmented skin shows hypertrophic scarring more visibly. Sun exposure permanently darkens scars regardless of location.
Specific complication rates differ between incisions — the technical access differences produce real outcome differences.
Capsular contracture rates. Inframammary: baseline rate (1-3% at 1 year, 5-10% at 10 years). Periareolar: 2-3x baseline rate (2-6% at 1 year, 10-20% at 10 years). Transaxillary: similar to baseline. Periareolar elevation thought to relate to bacterial contamination from milk ducts during pocket creation.
Infection rates. Inframammary: lowest rate (under 1% major infection). Periareolar: 2-3x higher infection rate. Transaxillary: intermediate. Periareolar elevation thought to relate to breast bacterial flora exposure during dissection.
Sensation changes. Inframammary: 3-5% permanent sensation change rate. Periareolar: 8-15% permanent rate. Transaxillary: 5-8% permanent rate. Periareolar approach passes through nerve plexus serving nipple-areolar complex.
Breastfeeding effects. Inframammary: minimal effect on breastfeeding. Periareolar: 5-10% reduction in breastfeeding capacity (cuts through milk ducts). Transaxillary: minimal effect on breastfeeding.
Pocket positioning accuracy. Inframammary: most precise. Periareolar: somewhat reduced precision. Transaxillary: most challenging precision (longest dissection path).
Revision capability. If revision needed, inframammary scar can be re-used. Periareolar can also be re-used but may require extending. Transaxillary often switched to inframammary for revision (better access).
Specific patient and anatomic factors favor each approach.
Inframammary preferred when: Standard primary augmentation in most patients. Larger implants planned (350cc+). Anatomical implants (better access for orientation). Future breastfeeding planned. Patient prioritizes minimum complication risk. Surgeon has standard preference (most surgeons).
Periareolar preferred when: Patient strongly desires no inframammary fold scar. Patient with very small/poorly defined inframammary fold (incision difficult to hide). Specific aesthetic situations requiring areolar reduction concurrent with augmentation. Patient understands and accepts higher complication rate trade-off.
Transaxillary preferred when: Patient strongly desires no scar on breast at all. Smaller implants planned (under 350cc — larger implants difficult through axillary route). Surgeon has specific expertise with transaxillary approach. Patient understands technical limitations.
Which to avoid when: Periareolar avoided if breastfeeding important, if patient has small areola (insufficient incision length), if very large implants planned. Transaxillary avoided if very large implants, if technical pocket control critical, if surgeon inexperienced with approach. Inframammary essentially universal — rarely contraindicated.
Patient counseling. Surgeon should discuss all three options with patient, explain trade-offs, recommend specific approach for patient's anatomy and goals. Patient should understand: scar location, complication rate differences, sensation impact differences, breastfeeding effects.
Default recommendation. Inframammary is default recommendation for most patients in modern practice. Specific patient preferences or anatomic factors may favor other approaches. Patients should require specific reasoning if surgeon recommends non-inframammary approach.
Specific patient profiles warrant specific incision considerations.
Patient planning future breastfeeding. Inframammary or transaxillary preferred. Periareolar may compromise breastfeeding. Inform surgeon of breastfeeding plans.
Patient with previous breast cancer or BRCA mutation. Inframammary preferred — preserves anatomic landmarks for future surveillance. Specific reconstruction scenarios may differ.
Patient with significant areolar size. If areola is large (4 cm+ diameter), periareolar incision can be hidden well. If small (under 3 cm), inadequate length for incision, periareolar usually inappropriate.
Patient with prominent inframammary fold. Well-defined fold provides excellent natural concealment for inframammary scar. Strong indication for inframammary approach.
Patient with poorly defined inframammary fold. Periareolar may produce more inconspicuous scar than inframammary in this scenario. Specific anatomic consideration.
Patient with hypertrophic scarring history. All incisions may produce raised scars. Inframammary scarring usually most concealed regardless. Discuss preventive scar treatments (silicone sheets, taping) with surgeon.
Patient with revision augmentation. Existing scar usually re-used — same incision as original. Sometimes indication to convert to inframammary if original was different approach (better access for revision).
Patient with desired areolar reduction. Periareolar can incorporate areolar reduction in same procedure. Specific advantage for patients wanting smaller areola.
Send a WhatsApp message to Dr. Erdal personally — every patient enquiry is reviewed and answered by Dr. Erdal directly, within 24 hours.